ESMO23
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ESMO23
Dec 31, 2023, 20:07 |
Blog
Katsuaki Maehara: Patritumab Deruxtecan (HER3-DXd) clinical trial transition
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared a post by EGFR Resisters on X/Twitter,…
Dec 19, 2023, 10:00 |
Blog
Amanda Nizam on biomarkers of TRAEs associated with EV for advanced urothelial carcinoma - GU Oncology Now
Amanda Nizam, a Genitourinary Medical Oncologist at Cleveland Clinic, recently shared a post by GU…
Dec 17, 2023, 17:21 |
Insight
SABCS23 Day 3 Highlights by Oncology Brothers
Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the third day's…
Dec 17, 2023, 03:29 |
Blog
Advancing the Battle Against Platinum-Resistant Ovarian Cancer: Promising Strategies from 2023 ASCO & ESMO Meetings
The 2023 ASCO and ESMO meetings provided novel insights for treating platinum-resistant ovarian cancer, a…
Dec 5, 2023, 19:22 |
Blog
Amy C. Moore: Chris Conneran's energy and passion is infectious!
Amy C. Moore, VP, Global Engagement and Patient Partnerships at LUNGevity Foundation, shared the following…
Nov 4, 2023, 00:33 |
Blog
Hripsime-Gina Martirosyan: Advocating for cancer care in Armenia: how it works in a resource-limited country
Hripsime-Gina Martirosyan, Founding CEO, Patient advocate at HENARAN charitable foundation, shared a post by HENARAN…
Nov 2, 2023, 01:12 |
Blog
Cristian Massacesi: I never fail to be impressed by my teams’ commitment in delivering science
Cristian Massacesi, Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca, made the following…
Nov 1, 2023, 14:40 |
Societies
Sarah Louden: ESMO23 USA in Florida
Sarah Louden, Founder and CEO of Total Health, stated the following on LinkedIn: ''What an…
Oct 31, 2023, 09:39 |
Insight
Paolo A. Ascierto: The history of melanoma is changing!
Paolo A. Ascierto, Director Department of Melanoma/Skin Cancers, Cancer Immunotherapy and Development Therapeutics at IRCCS,…
Oct 29, 2023, 17:37 |
Opinion
Mark Lanasa: The data we presented at ESMO are only the beginning of our story in solid tumors
Mark Lanasa, Chief Medical Officer of Solid Tumors at BeiGene, shared on LinkedIn: "I had…
1
2
3
4
5
All:
42
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube